SMG

Business Context and Reporting Period

Company: The Scotts Company (SCOTTS MIRACLE-GRO CO)

Filing Type: Form 10-Q (Quarterly Report)

Reporting Period: Three and nine months ended July 3, 1999

Business Overview: A leading manufacturer of lawn and garden care products operating in North America, Europe, and other global markets. The Company recently executed a major strategic shift by acquiring Monsanto's consumer lawn and garden business ("Ortho") and entering an exclusive marketing agreement for Roundup(R) herbicides.

Key Financial Metrics

Margin Analysis: Gross margin for the nine months ended July 3, 1999, was approximately 40.6% ($570.1M / $1,402.2M). Operating margin was approximately 14.6%.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 52.1% year-over-year, driven primarily by the inclusion of the newly acquired Ortho and Rhone-Poulenc Jardin (RPJ) businesses. On a pro forma basis (assuming acquisitions occurred in the prior year), sales grew 13.0%.
• Profitability: Net income increased 56.0% to $80.5 million. This growth was partially offset by an extraordinary loss of $5.8 million (net of tax) related to the early extinguishment of debt.
• Debt Levels: Total debt increased significantly by $560.4 million to $896.8 million. This increase funded the Ortho acquisition ($300M), the RPJ acquisition ($162M), and the repurchase of approximately 97% of the Company's outstanding 9 7/8% Senior Subordinated Notes.
• Acquisition Activity: The Company acquired Ortho (Jan 1999) and RPJ (Oct 1998), significantly expanding its product portfolio into pesticides and its geographic footprint in Europe.

Guidance, Outlook, and Risks

Management Commentary and Outlook

Management views the 1999 results as consistent with its long-term strategy for profitable growth. The Company aims to leverage its expanded portfolio (including the new Ortho and Roundup(R) agency rights) to achieve operational synergies and cost savings.

Strategic Financial Goals (4-Year Plan):

• Sales growth of 8% to 10%.
• Continued operating margin improvement.
• Minimum compounded annual EPS growth of 15%.
• Return on equity target of at least 15%.

Key Risks and Contingencies

• Substantial Leverage: The Company carries significant debt ($896.8M). Management notes that this leverage limits flexibility and increases vulnerability to adverse economic conditions or interest rate fluctuations.
• Weather and Seasonality: Sales are highly seasonal (approx. 72% in Q2 and Q3) and susceptible to weather conditions in North America and Europe.
• Roundup(R) Agreement Risks: The Company relies on the exclusive marketing agreement with Monsanto. Risks include the expiration of the glyphosate patent in the U.S. (Sept 2000), potential termination by Monsanto if sales decline, and ongoing FTC antitrust review.
• Environmental and Legal: Ongoing proceedings with the Ohio Environmental Protection Agency (OEPA) regarding the Marysville facility and a lawsuit filed by AgrEvo Environmental Health, Inc. alleging antitrust violations.
• Year 2000 Compliance: Estimated incremental costs for Y2K readiness are $5.7 million. Risks include potential disruptions from third-party suppliers.

Investor Verification Checklist

• Acquisition Integration: Verify the progress of integrating the Ortho and RPJ businesses and the realization of projected cost synergies.
• Debt Covenants: Review the financial covenants (minimum net worth, interest coverage, net leverage) in the new $1.025 billion credit facility to ensure compliance.
• Roundup(R) Commission: Monitor the EBIT performance of the global Roundup(R) business, as the Company's commission revenue ($27.5M for 9 months) is directly tied to these results.
• Environmental Reserves: Assess the adequacy of reserves for the Ohio EPA enforcement action and the potential impact of the AgrEvo lawsuit.
• Customer Concentration: Note that the top 10 customers accounted for ~50% of 1998 sales; monitor order stability from key retailers like The Home Depot and Wal*Mart.